|
In the know: JJB Sports, Shire, Vodafone and Plethora Solutions
Times Online, UK - 15 hours ago Plethora Solutions soared 8½p to 24p after the healthcare group announced positive phase III trials results for its treatment for premature ejaculation. … |
|
London pre-open: Slim loss to start
ShareCast, UK - 36 minutes ago Urology drug specialsit Plethora Solutions says its key premature ejaculation drug has met all of its goals in a European phase III trial. … |
 Business Wire (press release) |
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
Business Wire (press release), CA - Nov 7, 2008 There are currently no approved pharmaceutical treatments for premature ejaculation. PSD502 is applied locally "on demand" and is effective within five … Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK all 14 news articles |
|
Friday's news and tips
Investors Chronicle, UK - Nov 7, 2008 Urology drug specialist Plethora Solutions says its key premature ejaculation drug has met all of its goals in a European phase III trial. … |
|
Plethora premature ejaculation drug meets goals
Reuters UK, UK - Nov 6, 2008 L: Quote, Profile, Research) said on Friday its premature ejaculation drug has met all of its goals in a phase III trial. The company said PSD502, … Sciele Pharma and Plethora Solutions Announce Positive Phase III … Business Wire (press release) Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK Plethora hits target in European trial ShareCast Hemscott - GrowthBusiness.co.uk all 14 news articles |